Tibia / Medial Tibial Stress Syndrome / Shockwave / VAS+LEFS

This Circle helps physicians capture and monetize real-world data from their everyday delivery of Shockwave for Medial Tibial Stress Syndrome.

The Shockwave Market was valued at $1.34 Billion in 2023, and is estimated to grow to $2.4 Billion by 2030. Medial Tibial Stress Syndrome (MTSS), commonly known as Shin Splints, is one of the most common injuries in runners and athletes involved in high-impact sports. It's estimated that up to 16% of runners may experience MTSS at some point in their athletic careers. MTSS is seen more commonly in younger athletes, particularly in those aged 18-25, although it can affect individuals of all ages who engage in repetitive weight-bearing activities. With global life expectancy increasing, manufacturers will increase spending to obtain regulatory approvals for marketing shockwave products. Increasingly, that spend will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Medial Tibial Stress Syndrome cases, outcomes and other case data.